Veterinary Medicines

GALLIMUNE 407 ND+IB+EDS+ART, emulzija za injekciju, za kokoši

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
  • Egg drop syndrome '76 virus, strain V127, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
Download as PDF

Product identification

Medicine name:
GALLIMUNE 407 ND+IB+EDS+ART, emulzija za injekciju, za kokoši
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
  • Egg drop syndrome '76 virus, strain V127, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
    0.76
    log 10 optical density 50
    /
    0.30
    millilitre(s)
  • Egg drop syndrome '76 virus, strain V127, Inactivated
    180.00
    haemagglutination inhibiting unit(s)
    /
    0.30
    millilitre(s)
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    18.00
    haemagglutination inhibiting unit(s)
    /
    0.30
    millilitre(s)
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    50.00
    50% Protective Dose
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (layer hen)
    • Chicken (for reproduction)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA18
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/15-01/371
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."